MX9203787A - Composicion farmaceutica que contiene un portador farmaceuticamente adecuado y el compuesto que contiene la estructura (7 alfa, 17 alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en 20-in-3-ona. - Google Patents

Composicion farmaceutica que contiene un portador farmaceuticamente adecuado y el compuesto que contiene la estructura (7 alfa, 17 alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en 20-in-3-ona.

Info

Publication number: MX9203787A
Authority: MX; Mexico
Prior art keywords: alpha; pregn; methyl; pharmaceutical composition; hidroxi
Prior art date: 1989-03-18

Application number

MX9203787A

Other languages

English (en)

Inventor

Gerard Arnoud Jozef Maria Sas

Emili Martin Van Doornum

Original Assignee

Akzo Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-03-18

Filing date

1992-06-29

Publication date

1992-07-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19854317&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9203787(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1992-06-29 Application filed by Akzo Nv filed Critical Akzo Nv

1992-07-01 Publication of MX9203787A publication Critical patent/MX9203787A/es

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system

MX9203787A 1989-03-18 1992-06-29 Composicion farmaceutica que contiene un portador farmaceuticamente adecuado y el compuesto que contiene la estructura (7 alfa, 17 alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en 20-in-3-ona. MX9203787A (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
NL8900673		1989-03-18

Publications (1)

Publication Number	Publication Date
MX9203787A true MX9203787A (es)	1992-07-01

Family

ID=19854317

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MX9203787A MX9203787A (es)	1989-03-18	1992-06-29	Composicion farmaceutica que contiene un portador farmaceuticamente adecuado y el compuesto que contiene la estructura (7 alfa, 17 alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en 20-in-3-ona.

Country Status (17)

Country	Link
US (1)	US5037817A (es)
EP (1)	EP0389035B1 (es)
JP (2)	JP3139709B2 (es)
KR (1)	KR0183401B1 (es)
AT (1)	ATE98490T1 (es)
AU (1)	AU625083B2 (es)
CA (1)	CA2011452C (es)
DE (1)	DE69005165T2 (es)
DK (1)	DK0389035T3 (es)
ES (1)	ES2062292T3 (es)
FI (1)	FI94865C (es)
HK (1)	HK1002019A1 (es)
IE (1)	IE63051B1 (es)
MX (1)	MX9203787A (es)
NZ (1)	NZ232946A (es)
PT (1)	PT93488B (es)
ZA (1)	ZA901674B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE180669T1 (de) *	1993-03-05	1999-06-15	Akzo Nobel Nv	Verwendung von pregnanderivaten zur behandlung von tumoren
US6242434B1 (en) *	1997-08-08	2001-06-05	Bone Care International, Inc.	24-hydroxyvitamin D, analogs and uses thereof
IL123984A (en) *	1997-04-22	2004-09-27	Akzo Nobel Nv	Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable
PL197870B1 (pl) *	1998-10-16	2008-05-30	Organon Nv	Kompozycja o wysokiej czystości zawierająca (7α, 17α)-17-hydroksy-7-metylo-19-nor-17-pregn-5-(10)-en-20-yn-3-on, sposób wytwarzania tej kompozycji i farmaceutyczna jednostka dawkowania
US7045513B1 (en)	1999-03-18	2006-05-16	Genelabs Technologies, Inc.	DHEA composition and method
AU779138B2 (en) *	1999-03-18	2005-01-06	Genelabs Technologies, Inc.	DHEA composition and method
TWI265167B (en) *	1999-11-29	2006-11-01	Akzo Nobel Nv	3-methylene steroid derivatives
US20040229854A1 (en) *	2000-11-28	2004-11-18	Pieter Haan De	Immediate release dosage form for HRT
ATE364619T1 (de) *	2001-10-18	2007-07-15	Norton Healthcare Ltd	Tibolonformulierungen
GB0125061D0 (en) *	2001-10-18	2001-12-12	Norton Healthcare Ltd	Pharmaceutical composition
CN1620298A (zh) *	2002-01-22	2005-05-25	阿克佐诺贝尔公司	替勃龙用于治疗与施用阻止内源性***合成的药物有关的疾病
GB0304927D0 (en)	2003-03-04	2003-04-09	Resolution Chemicals Ltd	Process for the production of tibolone
CN1324041C (zh) *	2003-04-01	2007-07-04	上海迪赛诺医药科技开发有限公司	替勃龙晶型i的制备方法
PL1499278T3 (pl) *	2003-05-23	2005-09-30	Msd Oss Bv	Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon
EP1883648A1 (en) *	2005-05-23	2008-02-06	Newchem S.p.A.	Process for the preparation of pure crystalline tibolone
EP1821571A1 (en) *	2006-02-15	2007-08-22	Oticon A/S	Loop antenna for in the ear audio device
ITMI20130120A1 (it) *	2013-01-25	2014-07-26	Ind Chimica Srl	Processo per la preparazione in forma cristallina di tibolone, (7alfa,17alfa)-17-idrossi-7-metil-19-norpregn-5(10)-en-20-in-3-one
US10736907B2 (en)	2016-05-04	2020-08-11	Novalon S.A.	Use of sugar-alcohols in tibolone compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE665514A (es) *	1964-06-16
US4933168A (en) *	1975-05-27	1990-06-12	Syntex Pharmaceuticals International Limited	Stable, crystalline flunisolide
US4273710A (en) *	1979-05-21	1981-06-16	Syntex Corporation	Process for preparing flunisolide
US4447426A (en) *	1982-01-18	1984-05-08	E. R. Squibb & Sons, Inc.	Steroid monohydrates, formulations containing same and method
US4391755A (en) *	1982-01-18	1983-07-05	E. R. Squibb & Sons, Inc.	Steroid monohydrates, formulations containing same and method
US4701450A (en) *	1984-03-21	1987-10-20	Akzo N.V.	Steroids for use as immunomodulators

1990
- 1990-02-27 IE IE70990A patent/IE63051B1/en not_active IP Right Cessation
- 1990-03-05 CA CA002011452A patent/CA2011452C/en not_active Expired - Lifetime
- 1990-03-05 ZA ZA901674A patent/ZA901674B/xx unknown
- 1990-03-12 EP EP90200574A patent/EP0389035B1/en not_active Expired - Lifetime
- 1990-03-12 DE DE90200574T patent/DE69005165T2/de not_active Expired - Lifetime
- 1990-03-12 AT AT90200574T patent/ATE98490T1/de not_active IP Right Cessation
- 1990-03-12 DK DK90200574.3T patent/DK0389035T3/da active
- 1990-03-12 ES ES90200574T patent/ES2062292T3/es not_active Expired - Lifetime
- 1990-03-14 JP JP02063921A patent/JP3139709B2/ja not_active Expired - Lifetime
- 1990-03-15 US US07/494,089 patent/US5037817A/en not_active Expired - Lifetime
- 1990-03-16 NZ NZ232946A patent/NZ232946A/xx unknown
- 1990-03-16 AU AU51394/90A patent/AU625083B2/en not_active Expired
- 1990-03-16 FI FI901328A patent/FI94865C/fi active IP Right Grant
- 1990-03-16 PT PT93488A patent/PT93488B/pt not_active IP Right Cessation
- 1990-03-17 KR KR1019900003574A patent/KR0183401B1/ko not_active IP Right Cessation
1992
- 1992-06-29 MX MX9203787A patent/MX9203787A/es unknown
1998
- 1998-02-11 HK HK98101031A patent/HK1002019A1/xx not_active IP Right Cessation
2000
- 2000-10-17 JP JP2000316716A patent/JP2001139473A/ja active Pending

Also Published As

Publication number	Publication date
HK1002019A1 (en)	1998-07-24
JPH0347195A (ja)	1991-02-28
US5037817A (en)	1991-08-06
AU625083B2 (en)	1992-07-02
ATE98490T1 (de)	1994-01-15
FI901328A0 (fi)	1990-03-16
IE63051B1 (en)	1995-03-22
DE69005165T2 (de)	1994-05-05
ES2062292T3 (es)	1994-12-16
CA2011452C (en)	1999-05-25
DE69005165D1 (de)	1994-01-27
EP0389035B1 (en)	1993-12-15
JP3139709B2 (ja)	2001-03-05
KR900013950A (ko)	1990-10-22
IE900709L (en)	1990-09-18
DK0389035T3 (da)	1994-02-14
FI94865B (fi)	1995-07-31
PT93488B (pt)	1996-02-29
FI94865C (fi)	1995-11-10
ZA901674B (en)	1990-12-28
PT93488A (pt)	1990-11-07
CA2011452A1 (en)	1990-09-18
KR0183401B1 (ko)	1999-05-01
AU5139490A (en)	1990-09-20
EP0389035A1 (en)	1990-09-26
JP2001139473A (ja)	2001-05-22
NZ232946A (en)	1991-08-27

Similar Documents

Publication	Publication Date	Title
MX9203787A (es)	1992-07-01	Composicion farmaceutica que contiene un portador farmaceuticamente adecuado y el compuesto que contiene la estructura (7 alfa, 17 alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en 20-in-3-ona.
ATE227720T1 (de)	2002-11-15	1,3-oxathiolannukleosid-analoge verbindungen
LV5749A4 (lv)	1996-12-20	Farmaceitiska kompozicija kas satur ciklosporinus
IL84425A (en)	1993-07-08	(s) - (+) -ibuprofen-containing pharmaceutical compositions
DE68922801D1 (de)	1995-06-29	Flaschenkürbispulver-Zusammensetzung.
ES2062375T3 (es)	1994-12-16	Composiciones farmaceuticas que contienen un complejo de zinc.
SE8600017D0 (sv)	1986-01-03	New compound
ATE78166T1 (de)	1992-08-15	Monosaccharide enthaltende zusammensetzung zum heilen von wunden.
ES2085898T3 (es)	1996-06-16	Tratamiento de la enfermedad hepatobiliar con compuestos 15-cetoprostaglandina.
NO912992L (no)	1992-02-03	1-aminopropandiol-2,3 med hoey renhet, samt fremgangsmaate for fremstilling av forbindelsen.
KR910009270A (ko)	1991-06-28	15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법
IT8819731A0 (it)	1988-03-11	Composizioni farmaceutiche contenenti timosina alfa 1.
ES297099Y (es)	1989-12-16	Divisional del m. utilidad 296950 solicitado el 9-6-86
ES2072869T3 (es)	1995-08-01	Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo.
IT1224250B (it)	1990-09-26	Associzione del depiprazolo con la morfina
ES2032838T3 (es)	1993-03-01	Un procedimiento para preparar derivados tetrahidropirido (1,2-a)indol.
ATE81002T1 (de)	1992-10-15	Fixe arzneimittelkombination mit verzoegerter freisetzung.
IT1217837B (it)	1990-03-30	Procedimento per la preparazione del "alfa /4(1,1 dimetiletil)fenil/piperidinbutanolo"
ES2072090T3 (es)	1995-07-01	Derivados maleimidicos que contienen residuos acrilicos.
DE59207579D1 (de)	1997-01-09	Zusammensetzungen enthaltend mit Phosphonatgruppen substituierte N-Heterozyklen mit 6 Ringgliedern
ES555408A0 (es)	1987-02-16	Mejoras introducidas en el objeto de la patente principal n.532250 por:perfeccionamientos introducidas en un lapiz de labios giratorio.
IT8921095A0 (it)	1989-07-05	Composizione per l'aumento del guadagno di peso.
FR2575070B3 (fr)	1987-02-20	Composition a effet assainissant, en particulier pour le parfumage d'air ambiant
IT8919651A0 (it)	1989-03-03	Tavolo ad elevata flessibilita' di composizione.
IT8820059A0 (it)	1988-03-31	Apparecchio per illuminazione astruttura modulare, utilizzabile singolarmente od in piu' esemplari, variamente accoppiabili.